| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: InBiomotion |
| Recipient: You |
| Company: Cellworks |
| Recipient: You |
| Company: Xilis |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Cepheid |
| Recipient: You |
| Company: Epic Sciences |
| Recipient: You |
| Company: Cellworks |
| Recipient: You |
| Company: BioVica |
| Recipient: You |
| Company: xilis |
| Recipient: You |
| Company: Exact Sciences |
| Recipient: You |
| Company: Centrix |
| Recipient: You |
| Company: Arvinis |
| Recipient: You |
| Company: bioTheranostics |
| Recipient: You |
| Company: Strata |
| Recipient: You |
| Company: Stratipath |
| Recipient: You |
| Company: Artera |
| Recipient: You |
| Company: microbiologics |
| Recipient: You |
| Company: Delphi Diagnostics |
| Recipient: You |
| Company: Manta Cares |
| Recipient: You |
| Company: Spotlight Diagnostics |
| Recipient: You |
| Company: MIlagen |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Menarini Silicon Biosystems |
| Recipient: Your Institution |
| Company: Cepheid/Danaher |
| Recipient: Your Institution |
| Company: Angle |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: Royalties from licensed technology. |
| Recipient: You |
| Please describe: Diagnosis and Treatment of Breast Cancer. Patent No. US 8,790,878 B2. Date of Patent: Jul. 29, 2014. Applicant Proprietor: University of Michigan. Dr. Daniel F. Hayes is designated as inventor/co-inventor. |
| Recipient: You |
| Please describe: Circulating Tumor Cell Capturing Techniques and Devices. Patent No.: US 8,951,484 B2. Date of Patent: Feb. 10, 2015. Applicant Proprietor: University of Michigan. Dr. Daniel F. Hayes is designated as inventor/co-inventor. |
| Recipient: You |
| Please describe: Title: A method for predicting progression free and overall survival at each follow-up timepoint during therapy of metastatic breast cancer patients using circulating tumor cells. Patent no. 05725638.0-1223-US2005008602. |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: UpToDate |
| Recipient: You |
| Company: Cancer Expert Now |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|